시장보고서
상품코드
1762480

세계의 유방 조직 마커 시장 : 시장 규모, 점유율 및 동향, 업계 분석(제품별, 재료별, 용도별, 최종 용도별, 지역별), 예측(2025-2034년)

Breast Tissue Markers Market Size, Share, & Industry Analysis Report: By Product, By Material (Bio-absorbable and Non-absorbable), By Usage Type, By End Use, and By Region - Market Forecast, 2025-2034

발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 129 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면, 유방 조직 마커 시장 규모는 2034년까지 15억 566만 달러에 달할 것으로 예측됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 통찰력과 미래 시장 성장에 대한 분석을 제공합니다.

유방 조직 마커는 국소 마커 또는 의료기기로 불리며, 진단 및 치료 중 향후 식별을 위해 유방 내 이상 부위를 표시하는 데 사용되는 작은 임플란트입니다. 유방 조직 마커 시장은 이러한 마커를 영상 유도 워크플로우에 통합하여 시술의 정확성을 향상시킴으로써 성장하고 있습니다. 조직 마커의 사용은 암 생검에서 외과적 개입에 이르는 일련의 치료 과정을 통해 병변을 추적하는 데 있어 최소 침습적 시술에 대한 의존도가 높아짐에 따라 필수적인 요소로 자리 잡았습니다. 첨단 영상 진단 방식과의 호환성을 통해 임상의는 이전에 확인된 이상 부위를 정확하게 찾아내어 환자 예후와 시술의 효율성을 향상시킬 수 있습니다.

가시성과 생체적합성을 개선한 마커의 개발은 환자 중심의 개인 맞춤형 의료로의 광범위한 전환과 일치합니다. 제조업체들은 다양한 이미징 환경과 조직 밀도에 걸쳐 성능을 최적화하기 위해 마커의 소재와 형태를 혁신하는 데 점점 더 많은 노력을 기울이고 있습니다. 이러한 추세는 환자의 불편함을 최소화하면서 진단의 정확성과 시술의 안전성을 향상시키는 데 초점을 맞추고 있는 헬스케어 분야를 반영하고 있습니다. 그 결과, 유방 조직 마커 기술의 발전은 유방암 진단 및 치료 계획의 진보를 지속적으로 뒷받침하고 있습니다.

유방 조직 마커 시장 : 분석 개요

제품별로는 코일형 마커가 2024년 가장 높은 매출 점유율을 차지했으며, 이는 광범위한 임상적 활용과 저침습적 유방 시술에 쉽게 적용될 수 있기 때문인 것으로 분석됐습니다.

용도별로는 유방 보존 수술과 종양 제거 수술에서 정확한 위치 파악에 대한 수요 증가에 힘입어 수술 계획 부문이 가장 빠르게 성장할 것으로 예측됩니다.

북미는 정교한 의료 시스템, 종합적인 유방암 검진 도입, 환자/의료 서비스 제공업체의 높은 인식 수준으로 인해 2024년 가장 큰 매출 점유율을 차지했습니다.

아시아태평양의 유방 조직 마커 시장은 의료시설의 개선, 유방암 인식 제고 캠페인의 확대, 조기 발견 프로그램의 중요성 등에 힘입어 예측 기간 동안 큰 성장을 보일 것으로 예측됩니다.

세계 주요 시장 기업으로는 Argon Medical Devices, Becton Dickinson(BD), Carbon Medical Technologies, Inc. Endomagnetics Ltd,Hologic, Inc.,Medtronic,Merit Medical Systems,Mermaid Medical,Ranfac Corp,SOMATEX Medical Technologies 등이 있습니다.

목차

제1장 서론

제2장 주요 요약

제3장 분석 방법

제4장 세계의 유방 조직 마커 시장 인사이트

  • 시장 현황
  • 유방 조직 마커 시장 역학
    • 성장 촉진요인과 기회
    • 성장 억제요인과 과제
  • PESTLE 분석
  • 유방 조직 마커 시장 동향
  • 밸류체인 분석

제5장 세계의 유방 조직 마커 시장 : 제품별

  • 주요 조사 결과
  • 서론
  • Coil
  • Ribbon
  • Wing
  • U Shaped
  • Conic
  • Ring
  • Heart
  • Venus
  • 기타

제6장 세계의 유방 조직 마커 시장 : 재료별

  • 주요 분석 결과
  • 서론
  • 생체흡수성
  • 비흡수성

제7장 세계의 유방 조직 마커 시장 : 용도별

  • 주요 분석 결과
  • 생검
  • 수술 계획
  • 기타

제8장 세계의 유방 조직 마커 시장 : 최종 용도별

  • 주요 분석 결과
  • 서론
  • 병원
  • 외래수술센터(ASC)
  • 진단센터
  • 전문 클리닉

제9장 세계의 유방 조직 마커 시장 : 지역별

  • 주요 분석 결과
  • 서론
    • 유방 조직 마커 시장 분석 : 지역별(2020-2034년)
  • 북미
    • 북미 : 제품별(2020-2034년)
    • 북미 : 재료별(2020-2034년)
    • 북미 : 용도별(2020-2034년)
    • 북미 : 최종 용도별(2020-2034년)
    • 미국
    • 캐나다
  • 유럽
    • 유럽 : 제품별(2020-2034년)
    • 유럽 : 재료별(2020-2034년)
    • 유럽 : 용도별(2020-2034년)
    • 유럽 : 최종 용도별(2020-2034년)
    • 영국
    • 프랑스
    • 독일
    • 이탈리아
    • 스페인
    • 네덜란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 아시아태평양 : 제품별(2020-2034년)
    • 아시아태평양 : 재료별(2020-2034년)
    • 아시아태평양 : 용도별(2020-2034년)
    • 아시아태평양 : 최종 용도별(2020-2034년)
    • 중국
    • 인도
    • 말레이시아
    • 일본
    • 인도네시아
    • 한국
    • 호주
    • 기타 아시아태평양
  • 중동 및 아프리카
    • 중동 및 아프리카 : 제품별(2020-2034년)
    • 중동 및 아프리카 : 재료별(2020-2034년)
    • 중동 및 아프리카 : 용도별(2020-2034년)
    • 중동 및 아프리카 : 최종 용도별(2020-2034년)
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 남아프리카공화국
    • 기타 중동 및 아프리카
  • 라틴아메리카
    • 라틴아메리카 : 제품별(2020-2034년)
    • 라틴아메리카 : 재료별(2020-2034년)
    • 라틴아메리카 : 용도별(2020-2034년)
    • 라틴아메리카 : 최종 용도별(2020-2034년)
    • 멕시코
    • 브라질
    • 아르헨티나
    • 기타 라틴아메리카

제10장 경쟁 구도

  • 사업 확대, 기업 인수 분석
    • 사업 확대
    • 기업 인수
  • 제휴/협업/합의/공개

제11장 기업 개요

  • Argon Medical Devices
  • Becton Dickinson(BD)
  • Carbon Medical Technologies, Inc.
  • Cianna Medical
  • Cook Medical
  • Elucent Medical
  • Endomagnetics Ltd
  • Hologic, Inc.
  • Medtronic
  • Merit Medical Systems
  • Mermaid Medical
  • Ranfac Corp
  • SOMATEX Medical Technologies
  • Sterylab
  • Tsunami S.r.l.
LSH 25.07.14

The breast tissue markers market size is expected to reach USD 1,505.66 million by 2034, according to a new study by Polaris Market Research. The report "Breast Tissue Markers Market Share, Size, & Industry Analysis Report: By Product, By Material (Bio-absorbable and Non-absorbable), By Usage Type, By End Use, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Breast tissue markers, referred to as localization markers or medical device, are tiny implants used to mark the site of abnormalities within the breast for future identification during diagnosis or treatment. The breast tissue markers market is growing due to the integration of these markers into image-guided workflows to improve procedural accuracy. The use of tissue markers has become essential for tracking lesions throughout the care continuum from cancer biopsy to surgical intervention with the increasing reliance on minimally invasive techniques. Their compatibility with advanced imaging modalities allows clinicians to precisely locate previously identified abnormalities, thereby improving patient outcomes and procedural efficiency.

The development of markers with improved visibility and biocompatibility aligns with the broader shift toward patient-centered, personalized care. Manufacturers are increasingly focusing on innovation in marker materials and shapes to optimize their performance across different imaging environments and tissue densities. This trend reflects the healthcare sector's emphasis on refining diagnostic precision and procedural safety while minimizing patient discomfort. As a result, the evolution of breast tissue marker technologies continues to support advancements in breast cancer detection and treatment planning.

Breast Tissue Markers Market Report Highlights

In terms of product, the coil-based markers segment accounted for the highest revenue share in 2024, driven by their broad clinical utilization and straightforward application in minimally invasive breast procedures.

Based on usage type, the surgical planning segment is anticipated to experience the most rapid expansion, fueled by rising demand for precise localization in breast-conserving surgeries and tumor removal procedures.

North America held the largest revenue share in 2024, attributed to its sophisticated healthcare systems, comprehensive breast cancer screening adoption, and high patient/provider awareness levels.

The Asia Pacific breast tissue markers market is expected to show significant growth during the forecast period, supported by improving healthcare facilities, expanding breast cancer awareness campaigns, and greater emphasis on early detection programs.

A few global key market players include Argon Medical Devices, Becton Dickinson (BD), Carbon Medical Technologies, Inc., Cianna Medical, Cook Medical, Elucent Medical, Endomagnetics Ltd, Hologic, Inc., Medtronic, Merit Medical Systems, Mermaid Medical, Ranfac Corp, SOMATEX Medical Technologies.

Polaris Market Research has segmented the breast tissue markers market report on the basis of product, material, usage type, end use, and region:

By Product Outlook (Revenue, USD Million, 2020-2034)

Coil

Ribbon

Wing

U Shaped

Conic

Ring

Heart

Venus

Others

By Material Outlook (Revenue, USD Million, 2020-2034)

Bio-absorbable

Non-absorbable

By Usage Type Outlook (Revenue, USD Million, 2020-2034)

Biopsy

Stereotactic

Ultrasound

MRI-guided

Surgical Planning

Others

By End Use Outlook (Revenue, USD Million, 2020-2034)

Hospitals

Ambulatory Surgical Centers (ASCs)

Diagnostic Centers

Specialty Clinics

By Regional Outlook (Revenue, USD Million, 2020-2034)

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Breast Tissue Markers Market Insights

  • 4.1. Breast Tissue Markers Market - Market Snapshot
  • 4.2. Breast Tissue Markers Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Incidence of Breast Cancer
      • 4.2.1.2. Advancements in Imaging and Diagnostic Technologies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost and Limited Access in Low-Resource Settings
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Breast Tissue Markers Market Trends
  • 4.6. Value Chain Analysis

5. Global Breast Tissue Markers Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Breast Tissue Markers Market, by Product, 2020-2034 (USD million)
  • 5.3. Coil
    • 5.3.1. Global Breast Tissue Markers Market, by Coil, by Region, 2020-2034 (USD million)
  • 5.4. Ribbon
    • 5.4.1. Global Breast Tissue Markers Market, by Ribbon, by Region, 2020-2034 (USD million)
  • 5.5. Wing
    • 5.5.1. Global Breast Tissue Markers Market, by Wing, by Region, 2020-2034 (USD million)
  • 5.6. U Shaped
    • 5.6.1. Global Breast Tissue Markers Market, by U Shaped, by Region, 2020-2034 (USD million)
  • 5.7. Conic
    • 5.7.1. Global Breast Tissue Markers Market, by Conic, by Region, 2020-2034 (USD million)
  • 5.8. Ring
    • 5.8.1. Global Breast Tissue Markers Market, by Ring, by Region, 2020-2034 (USD million)
  • 5.9. Heart
    • 5.9.1. Global Breast Tissue Markers Market, by Heart, by Region, 2020-2034 (USD million)
  • 5.10. Venus
    • 5.10.1. Global Breast Tissue Markers Market, by Venus, by Region, 2020-2034 (USD million)
  • 5.11. Others
    • 5.11.1. Global Breast Tissue Markers Market, by Others, by Region, 2020-2034 (USD million)

6. Global Breast Tissue Markers Market, by Material

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Breast Tissue Markers Market, by Material, 2020-2034 (USD million)
  • 6.3. Bio-absorbable
    • 6.3.1. Global Breast Tissue Markers Market, by Bio-absorbable, by Region, 2020-2034 (USD million)
  • 6.4. Non-absorbable
    • 6.4.1. Global Breast Tissue Markers Market, by Non-absorbable, by Region, 2020-2034 (USD million)

7. Global Breast Tissue Markers Market, by Usage Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Breast Tissue Markers Market, by Biopsy, 2020-2034 (USD million)
  • 7.3. Biopsy
    • 7.3.1. Global Breast Tissue Markers Market, by Hospitals, by Region, 2020-2034 (USD million)
    • 7.3.2. Stereotactic
      • 7.3.2.1. Global Breast Tissue Markers Market, by Stereotactic, by Region, 2020-2034 (USD million)
    • 7.3.3. Ultrasound
      • 7.3.3.1. Global Breast Tissue Markers Market, by Ultrasound, by Region, 2020-2034 (USD million)
    • 7.3.4. MRI-guided
      • 7.3.4.1. Global Breast Tissue Markers Market, by MRI-guided, by Region, 2020-2034 (USD million)
  • 7.4. Surgical Planning
    • 7.4.1. Global Breast Tissue Markers Market, by Surgical Planning, by Region, 2020-2034 (USD million)
  • 7.5. Others
    • 7.5.1. Global Breast Tissue Markers Market, by Others, by Region, 2020-2034 (USD million)

8. Global Breast Tissue Markers Market, by End Use

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Breast Tissue Markers Market, by End Use, 2020-2034 (USD million)
  • 8.3. Hospitals
    • 8.3.1. Global Breast Tissue Markers Market, by Hospitals, by Region, 2020-2034 (USD million)
  • 8.4. Ambulatory Surgical Centers (ASCs)
    • 8.4.1. Global Breast Tissue Markers Market, by Ambulatory Surgical Centers (ASCs), by Region, 2020-2034 (USD million)
  • 8.5. Diagnostic Centers
    • 8.5.1. Global Breast Tissue Markers Market, by Diagnostic Centers, by Region, 2020-2034 (USD million)
  • 8.6. Specialty Clinics
    • 8.6.1. Global Breast Tissue Markers Market, by Specialty Clinics, by Region, 2020-2034 (USD million)

9. Global Breast Tissue Markers Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Breast Tissue Markers Market Assessment, By Geography, 2020-2034 (USD million)
  • 9.3. Breast Tissue Markers Market - North America
    • 9.3.1. North America: Breast Tissue Markers Market, by Product, 2020-2034 (USD million)
    • 9.3.2. North America: Breast Tissue Markers Market, by Material, 2020-2034 (USD million)
    • 9.3.3. North America: Breast Tissue Markers Market, by Usage Type, 2020-2034 (USD million)
    • 9.3.4. North America: Breast Tissue Markers Market, by End Use, 2020-2034 (USD million)
    • 9.3.5. Breast Tissue Markers Market - US
      • 9.3.5.1. US: Breast Tissue Markers Market, by Product, 2020-2034 (USD million)
      • 9.3.5.2. US: Breast Tissue Markers Market, by Material, 2020-2034 (USD million)
      • 9.3.5.3. US: Breast Tissue Markers Market, by Usage Type, 2020-2034 (USD million)
      • 9.3.5.4. US: Breast Tissue Markers Market, by End Use, 2020-2034 (USD million)
    • 9.3.6. Breast Tissue Markers Market - Canada
      • 9.3.6.1. Canada: Breast Tissue Markers Market, by Product, 2020-2034 (USD million)
      • 9.3.6.2. Canada: Breast Tissue Markers Market, by Material, 2020-2034 (USD million)
      • 9.3.6.3. Canada: Breast Tissue Markers Market, by Usage Type, 2020-2034 (USD million)
      • 9.3.6.4. Canada: Breast Tissue Markers Market, by End Use, 2020-2034 (USD million)
  • 9.4. Breast Tissue Markers Market - Europe
    • 9.4.1. Europe: Breast Tissue Markers Market, by Product, 2020-2034 (USD million)
    • 9.4.2. Europe: Breast Tissue Markers Market, by Material, 2020-2034 (USD million)
    • 9.4.3. Europe: Breast Tissue Markers Market, by Usage Type, 2020-2034 (USD million)
    • 9.4.4. Europe: Breast Tissue Markers Market, by End Use, 2020-2034 (USD million)
    • 9.4.5. Breast Tissue Markers Market - UK
      • 9.4.5.1. UK: Breast Tissue Markers Market, by Product, 2020-2034 (USD million)
      • 9.4.5.2. UK: Breast Tissue Markers Market, by Material, 2020-2034 (USD million)
      • 9.4.5.3. UK: Breast Tissue Markers Market, by Usage Type, 2020-2034 (USD million)
      • 9.4.5.4. UK: Breast Tissue Markers Market, by End Use, 2020-2034 (USD million)
    • 9.4.6. Breast Tissue Markers Market - France
      • 9.4.6.1. France: Breast Tissue Markers Market, by Product, 2020-2034 (USD million)
      • 9.4.6.2. France: Breast Tissue Markers Market, by Material, 2020-2034 (USD million)
      • 9.4.6.3. France: Breast Tissue Markers Market, by Usage Type, 2020-2034 (USD million)
      • 9.4.6.4. France: Breast Tissue Markers Market, by End Use, 2020-2034 (USD million)
    • 9.4.7. Breast Tissue Markers Market - Germany
      • 9.4.7.1. Germany: Breast Tissue Markers Market, by Product, 2020-2034 (USD million)
      • 9.4.7.2. Germany: Breast Tissue Markers Market, by Material, 2020-2034 (USD million)
      • 9.4.7.3. Germany: Breast Tissue Markers Market, by Usage Type, 2020-2034 (USD million)
      • 9.4.7.4. Germany: Breast Tissue Markers Market, by End Use, 2020-2034 (USD million)
    • 9.4.8. Breast Tissue Markers Market - Italy
      • 9.4.8.1. Italy: Breast Tissue Markers Market, by Product, 2020-2034 (USD million)
      • 9.4.8.2. Italy: Breast Tissue Markers Market, by Material, 2020-2034 (USD million)
      • 9.4.8.3. Italy: Breast Tissue Markers Market, by Usage Type, 2020-2034 (USD million)
      • 9.4.8.4. Italy: Breast Tissue Markers Market, by End Use, 2020-2034 (USD million)
    • 9.4.9. Breast Tissue Markers Market - Spain
      • 9.4.9.1. Spain: Breast Tissue Markers Market, by Product, 2020-2034 (USD million)
      • 9.4.9.2. Spain: Breast Tissue Markers Market, by Material, 2020-2034 (USD million)
      • 9.4.9.3. Spain: Breast Tissue Markers Market, by Usage Type, 2020-2034 (USD million)
      • 9.4.9.4. Spain: Breast Tissue Markers Market, by End Use, 2020-2034 (USD million)
    • 9.4.10. Breast Tissue Markers Market - Netherlands
      • 9.4.10.1. Netherlands: Breast Tissue Markers Market, by Product, 2020-2034 (USD million)
      • 9.4.10.2. Netherlands: Breast Tissue Markers Market, by Material, 2020-2034 (USD million)
      • 9.4.10.3. Netherlands: Breast Tissue Markers Market, by Usage Type, 2020-2034 (USD million)
      • 9.4.10.4. Netherlands: Breast Tissue Markers Market, by End Use, 2020-2034 (USD million)
    • 9.4.11. Breast Tissue Markers Market - Russia
      • 9.4.11.1. Russia: Breast Tissue Markers Market, by Product, 2020-2034 (USD million)
      • 9.4.11.2. Russia: Breast Tissue Markers Market, by Material, 2020-2034 (USD million)
      • 9.4.11.3. Russia: Breast Tissue Markers Market, by Usage Type, 2020-2034 (USD million)
      • 9.4.11.4. Russia: Breast Tissue Markers Market, by End Use, 2020-2034 (USD million)
    • 9.4.12. Breast Tissue Markers Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Breast Tissue Markers Market, by Product, 2020-2034 (USD million)
      • 9.4.12.2. Rest of Europe: Breast Tissue Markers Market, by Material, 2020-2034 (USD million)
      • 9.4.12.3. Rest of Europe: Breast Tissue Markers Market, by Usage Type, 2020-2034 (USD million)
      • 9.4.12.4. Rest of Europe: Breast Tissue Markers Market, by End Use, 2020-2034 (USD million)
  • 9.5. Breast Tissue Markers Market - Asia Pacific
    • 9.5.1. Asia Pacific: Breast Tissue Markers Market, by Product, 2020-2034 (USD million)
    • 9.5.2. Asia Pacific: Breast Tissue Markers Market, by Material, 2020-2034 (USD million)
    • 9.5.3. Asia Pacific: Breast Tissue Markers Market, by Usage Type, 2020-2034 (USD million)
    • 9.5.4. Asia Pacific: Breast Tissue Markers Market, by End Use, 2020-2034 (USD million)
    • 9.5.5. Breast Tissue Markers Market - China
      • 9.5.5.1. China: Breast Tissue Markers Market, by Product, 2020-2034 (USD million)
      • 9.5.5.2. China: Breast Tissue Markers Market, by Material, 2020-2034 (USD million)
      • 9.5.5.3. China: Breast Tissue Markers Market, by Usage Type, 2020-2034 (USD million)
      • 9.5.5.4. China: Breast Tissue Markers Market, by End Use, 2020-2034 (USD million)
    • 9.5.6. Breast Tissue Markers Market - India
      • 9.5.6.1. India: Breast Tissue Markers Market, by Product, 2020-2034 (USD million)
      • 9.5.6.2. India: Breast Tissue Markers Market, by Material, 2020-2034 (USD million)
      • 9.5.6.3. India: Breast Tissue Markers Market, by Usage Type, 2020-2034 (USD million)
      • 9.5.6.4. India: Breast Tissue Markers Market, by End Use, 2020-2034 (USD million)
    • 9.5.7. Breast Tissue Markers Market - Malaysia
      • 9.5.7.1. Malaysia: Breast Tissue Markers Market, by Product, 2020-2034 (USD million)
      • 9.5.7.2. Malaysia: Breast Tissue Markers Market, by Material, 2020-2034 (USD million)
      • 9.5.7.3. Malaysia: Breast Tissue Markers Market, by Usage Type, 2020-2034 (USD million)
      • 9.5.7.4. Malaysia: Breast Tissue Markers Market, by End Use, 2020-2034 (USD million)
    • 9.5.8. Breast Tissue Markers Market - Japan
      • 9.5.8.1. Japan: Breast Tissue Markers Market, by Product, 2020-2034 (USD million)
      • 9.5.8.2. Japan: Breast Tissue Markers Market, by Material, 2020-2034 (USD million)
      • 9.5.8.3. Japan: Breast Tissue Markers Market, by Usage Type, 2020-2034 (USD million)
      • 9.5.8.4. Japan: Breast Tissue Markers Market, by End Use, 2020-2034 (USD million)
    • 9.5.9. Breast Tissue Markers Market - Indonesia
      • 9.5.9.1. Indonesia: Breast Tissue Markers Market, by Product, 2020-2034 (USD million)
      • 9.5.9.2. Indonesia: Breast Tissue Markers Market, by Material, 2020-2034 (USD million)
      • 9.5.9.3. Indonesia: Breast Tissue Markers Market, by Usage Type, 2020-2034 (USD million)
      • 9.5.9.4. Indonesia: Breast Tissue Markers Market, by End Use, 2020-2034 (USD million)
    • 9.5.10. Breast Tissue Markers Market - South Korea
      • 9.5.10.1. South Korea: Breast Tissue Markers Market, by Product, 2020-2034 (USD million)
      • 9.5.10.2. South Korea: Breast Tissue Markers Market, by Material, 2020-2034 (USD million)
      • 9.5.10.3. South Korea: Breast Tissue Markers Market, by Usage Type, 2020-2034 (USD million)
      • 9.5.10.4. South Korea: Breast Tissue Markers Market, by End Use, 2020-2034 (USD million)
    • 9.5.11. Breast Tissue Markers Market - Australia
      • 9.5.11.1. Australia: Breast Tissue Markers Market, by Product, 2020-2034 (USD million)
      • 9.5.11.2. Australia: Breast Tissue Markers Market, by Material, 2020-2034 (USD million)
      • 9.5.11.3. Australia: Breast Tissue Markers Market, by Usage Type, 2020-2034 (USD million)
      • 9.5.11.4. Australia: Breast Tissue Markers Market, by End Use, 2020-2034 (USD million)
    • 9.5.12. Breast Tissue Markers Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Breast Tissue Markers Market, by Product, 2020-2034 (USD million)
      • 9.5.12.2. Rest of Asia Pacific: Breast Tissue Markers Market, by Material, 2020-2034 (USD million)
      • 9.5.12.3. Rest of Asia Pacific: Breast Tissue Markers Market, by Usage Type, 2020-2034 (USD million)
      • 9.5.12.4. Rest of Asia Pacific: Breast Tissue Markers Market, by End Use, 2020-2034 (USD million)
  • 9.6. Breast Tissue Markers Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Breast Tissue Markers Market, by Product, 2020-2034 (USD million)
    • 9.6.2. Middle East & Africa: Breast Tissue Markers Market, by Material, 2020-2034 (USD million)
    • 9.6.3. Middle East & Africa: Breast Tissue Markers Market, by Usage Type, 2020-2034 (USD million)
    • 9.6.4. Middle East & Africa: Breast Tissue Markers Market, by End Use, 2020-2034 (USD million)
    • 9.6.5. Breast Tissue Markers Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Breast Tissue Markers Market, by Product, 2020-2034 (USD million)
      • 9.6.5.2. Saudi Arabia: Breast Tissue Markers Market, by Material, 2020-2034 (USD million)
      • 9.6.5.3. Saudi Arabia: Breast Tissue Markers Market, by Usage Type, 2020-2034 (USD million)
      • 9.6.5.4. Saudi Arabia: Breast Tissue Markers Market, by End Use, 2020-2034 (USD million)
    • 9.6.6. Breast Tissue Markers Market - UAE
      • 9.6.6.1. UAE: Breast Tissue Markers Market, by Product, 2020-2034 (USD million)
      • 9.6.6.2. UAE: Breast Tissue Markers Market, by Material, 2020-2034 (USD million)
      • 9.6.6.3. UAE: Breast Tissue Markers Market, by Usage Type, 2020-2034 (USD million)
      • 9.6.6.4. UAE: Breast Tissue Markers Market, by End Use, 2020-2034 (USD million)
    • 9.6.7. Breast Tissue Markers Market - Israel
      • 9.6.7.1. Israel: Breast Tissue Markers Market, by Product, 2020-2034 (USD million)
      • 9.6.7.2. Israel: Breast Tissue Markers Market, by Material, 2020-2034 (USD million)
      • 9.6.7.3. Israel: Breast Tissue Markers Market, by Usage Type, 2020-2034 (USD million)
      • 9.6.7.4. Israel: Breast Tissue Markers Market, by End Use, 2020-2034 (USD million)
    • 9.6.8. Breast Tissue Markers Market - South Africa
      • 9.6.8.1. South Africa: Breast Tissue Markers Market, by Product, 2020-2034 (USD million)
      • 9.6.8.2. South Africa: Breast Tissue Markers Market, by Material, 2020-2034 (USD million)
      • 9.6.8.3. South Africa: Breast Tissue Markers Market, by Usage Type, 2020-2034 (USD million)
      • 9.6.8.4. South Africa: Breast Tissue Markers Market, by End Use, 2020-2034 (USD million)
    • 9.6.9. Breast Tissue Markers Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Breast Tissue Markers Market, by Product, 2020-2034 (USD million)
      • 9.6.9.2. Rest of Middle East & Africa: Breast Tissue Markers Market, by Material, 2020-2034 (USD million)
      • 9.6.9.3. Rest of Middle East & Africa: Breast Tissue Markers Market, by Usage Type, 2020-2034 (USD million)
      • 9.6.9.4. Rest of Middle East & Africa: Breast Tissue Markers Market, by End Use, 2020-2034 (USD million)
  • 9.7. Breast Tissue Markers Market - Latin America
    • 9.7.1. Latin America: Breast Tissue Markers Market, by Product, 2020-2034 (USD million)
    • 9.7.2. Latin America: Breast Tissue Markers Market, by Material, 2020-2034 (USD million)
    • 9.7.3. Latin America: Breast Tissue Markers Market, by Usage Type, 2020-2034 (USD million)
    • 9.7.4. Latin America: Breast Tissue Markers Market, by End Use, 2020-2034 (USD million)
    • 9.7.5. Breast Tissue Markers Market - Mexico
      • 9.7.5.1. Mexico: Breast Tissue Markers Market, by Product, 2020-2034 (USD million)
      • 9.7.5.2. Mexico: Breast Tissue Markers Market, by Material, 2020-2034 (USD million)
      • 9.7.5.3. Mexico: Breast Tissue Markers Market, by Usage Type, 2020-2034 (USD million)
      • 9.7.5.4. Mexico: Breast Tissue Markers Market, by End Use, 2020-2034 (USD million)
    • 9.7.6. Breast Tissue Markers Market - Brazil
      • 9.7.6.1. Brazil: Breast Tissue Markers Market, by Product, 2020-2034 (USD million)
      • 9.7.6.2. Brazil: Breast Tissue Markers Market, by Material, 2020-2034 (USD million)
      • 9.7.6.3. Brazil: Breast Tissue Markers Market, by Usage Type, 2020-2034 (USD million)
      • 9.7.6.4. Brazil: Breast Tissue Markers Market, by End Use, 2020-2034 (USD million)
    • 9.7.7. Breast Tissue Markers Market - Argentina
      • 9.7.7.1. Argentina: Breast Tissue Markers Market, by Product, 2020-2034 (USD million)
      • 9.7.7.2. Argentina: Breast Tissue Markers Market, by Material, 2020-2034 (USD million)
      • 9.7.7.3. Argentina: Breast Tissue Markers Market, by Usage Type, 2020-2034 (USD million)
      • 9.7.7.4. Argentina: Breast Tissue Markers Market, by End Use, 2020-2034 (USD million)
    • 9.7.8. Breast Tissue Markers Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Breast Tissue Markers Market, by Product, 2020-2034 (USD million)
      • 9.7.8.2. Rest of Latin America: Breast Tissue Markers Market, by Material, 2020-2034 (USD million)
      • 9.7.8.3. Rest of Latin America: Breast Tissue Markers Market, by Usage Type, 2020-2034 (USD million)
      • 9.7.8.4. Rest of Latin America: Breast Tissue Markers Market, by End Use, 2020-2034 (USD million)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Argon Medical Devices
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Becton Dickinson (BD)
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Carbon Medical Technologies, Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Cianna Medical
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Cook Medical
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Elucent Medical
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Endomagnetics Ltd
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Hologic, Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Medtronic
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Merit Medical Systems
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Mermaid Medical
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Ranfac Corp
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. SOMATEX Medical Technologies
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Sterylab
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. Tsunami S.r.l.
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제